Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: No national studies comparing long-term survival after total or partial gastrectomy with splenectomy due to injury or oncologic reasons or spleen preservation exist. This study aimed to examine the 5-year overall survival (OS) of patients with gastric adenocarcinoma who underwent total or partial gastrectomy with splenectomy due to injury or oncologic reasons or spleen preservation in a population-based nationwide setting.
Methods: This study included all patients undergoing total or partial gastrectomy with splenectomy or spleen preservation for gastric adenocarcinoma in Finland from 2005 to 2016, with follow-up until December 31, 2019. A total of 2196 patients with gastric cancer diagnosis and total or partial gastrectomy were identified in the registries. Of these patients, 2118 were applicable for this study. Cox proportional hazard models provided hazard ratios (HRs) with 95% CIs of 5-year OS. The results were adjusted for age, sex, year of operation, comorbidities, tumor location, pathologic stage, and neoadjuvant therapy.
Results: The observed 5-year OS rates were 38.7% in patients with no or minor spleen injury, 39.7% in patients with splenectomy due to injury, and 30.8% in patients with splenectomy due to oncologic reasons (P = .032). Patients who underwent R0 gastrectomy with splenectomy due to oncologic reasons had higher 5-year mortality (the adjusted model HR, 1.26; 95% CI, 1.01-1.56) than patients who underwent spleen preservation.
Conclusion: The OS was worst in patients who underwent gastrectomy with splenectomy due to oncologic reasons, highlighting the poor prognosis in patients with advanced gastric cancer. Splenectomy due to injury does not compromise the prognosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gassur.2024.10.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Application of combined multiple organ resection in the treatment of locally advanced gastric cancer.
Medicine (Baltimore)
August 2025
Department of General Surgery, Qinghai Provincial People's Hospital, Xining City, Qinghai Province, China.
This study analyzes the application value of extended multi-organ resection in the treatment of locally advanced gastric cancer, and to provide reference for the clinical diagnosis and treatment of locally advanced gastric cancer patients. From January 2016 to April 2022, 64 cases of locally advanced gastric cancer admitted to our hospital were analyzed retrospectively. Combined multiple organ resection was used as the treatment strategy, and the general information and surgical data of patients were analyzed to evaluate the prognosis of extended multi-organ resection in the treatment of locally advanced gastric cancer and the factors affecting these clinical outcomes.
View Article and Find Full Text PDFCombined splenectomy and robotic subtotal gastrectomy with short gastric vessel salvation for gastric cancer with SANT of the spleen: A case report.
Int J Surg Case Rep
August 2025
Department of Surgery, Yonsei University College of Medicine, 50-1, Yonsei-Ro, Seodaemun-gu, Seoul 03722, Republic of Korea. Electronic address:
Introduction And Importance: Surgical methods to treat gastric cancer are quite straightforward. However, in rare cases of gastric cancer accompanied by a splenic mass that requires splenectomy, treatment options become much more complicated. Splenectomy can effectively treat splenic masses, but without adequate salvation of vessels, could increase the risk of ischemic necrosis if simultaneously performed with distal subtotal gastrectomy.
View Article and Find Full Text PDFA 69-year-old man was referred to our hospital due to a rapid increase of HbA1c. Computed tomography(CT)showed a 40 mm hypo vascular tumor in the body of the pancreas, which was diagnosed as pancreatic squamous cell carcinoma by endoscopic ultrasound-fine needle aspiration. Also, esophagogastroduodenoscopy(EGD)revealed a type 2 tumor in the body of the stomach, which was diagnosed as well differentiated gastric cancer.
View Article and Find Full Text PDFAssociation of Preoperative Hematocrit and Intraoperative/Postoperative Transfusion Volume With Outcomes of Major Abdominal Surgery.
Am Surg
April 2025
Cardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
BackgroundDespite the independent effect of lower preoperative hematocrit levels and higher transfusion volumes with increased postoperative morbidity and mortality, the impact of the interplay between these variables on outcomes remains poorly understood. We hypothesized that after adjusting for preoperative hematocrit, red cell transfusions exhibit a stepwise association with increased mortality and complications after major abdominal surgery (MAS).MethodsAll adults (≥18 years) undergoing elective MAS (colectomy, enterectomy, proctectomy, laparotomy, splenectomy, gastrectomy, enterorrhaphy/colorrhaphy, and peritoneal drainage) were identified in the 2020-2022 American College of Surgeons National Surgical Quality Improvement Program database.
View Article and Find Full Text PDFShort- and long-term outcomes after perioperative EOX therapy versus upfront surgery for gastric cancer: a single-centre propensity score-matched cohort study.
BMC Surg
April 2025
Department of Abdominal Surgery, Helsinki University Hospital and University of Helsinki, Meilahti Tower Hospital, Building 1, Haartmaninkatu 4, PO Box 340, Helsinki, 00029 HUS, Finland.
Introduction: Despite radical surgery, gastric cancer (GC) survival rates remain low in Western countries. Randomised trials suggest that perioperative chemotherapy downstages disease, improving long-term survival without increasing complications. We compared outcomes for upfront surgery (US) versus surgery combined with perioperative EOX (epirubicin, oxaliplatin, capecitabine) therapy for short- and long-term survival.
View Article and Find Full Text PDF